Live Breaking News & Updates on British society for immunology

Stay informed with the latest breaking news from British society for immunology on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in British society for immunology and stay connected to the pulse of your community

'This is urgent': the UK is scrambling to stem an alarming tide of measles | MMR

How did the country get from a 2017 WHO declaration that the disease had been eliminated in Britain to the current crisis?

West-midlands , United-kingdom-general- , United-kingdom , London , City-of , Britain , British , Helen-bedford , Andrew-wakefield , Ronny-cheung , Stuart-neil , Andrew-pollard

'Children will die' if disease sweeping UK not taken seriously, expert says

'Children will die' if disease sweeping UK not taken seriously, expert says
birminghammail.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from birminghammail.co.uk Daily Mail and Mail on Sunday newspapers.

West-midlands , United-kingdom-general- , United-kingdom , London , City-of , British , Ronny-cheung , Steve-russell , David-elliman , Doug-brown , Vanessa-saliba , Royal-college-of-paediatrics

Measles: Urgent vaccine plea as London cases treble in a year

Measles: Urgent vaccine plea as London cases treble in a year
standard.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from standard.co.uk Daily Mail and Mail on Sunday newspapers.

United-kingdom , British , Doug-brown , British-society-for-immunology , Chief-executive , British-society ,

SpyBiotech Announces First Patient Dosed in Phase I Trial of SPYVLP01

SpyBiotech Announces First Patient Dosed in Phase I Trial of SPYVLP01
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United-kingdom , British , Karen-sharma , Maria-stacey , Mark-leuchtenberger , Adam-michael , Spytag-spycatcher , Stefan-klotter , Sarah-macleod , University-of-oxford , Cardiff-university , Powerscourt-group

What do we know about covid in immunocompromised people?

Katharine Lang looks at the continuing dangers of covid for immunocompromised people, the treatments available to them, and how antivirals such as remdesivir may help

### Is covid still a particular risk for people who are immunocompromised?

Although the morbidity and mortality of covid-19 have reduced drastically in highly vaccinated and highly previously exposed populations, the disease is still a threat to the lives of more vulnerable people, particularly those without a functioning immune system. They are the people at “greatest risk,” says Bill Schaffner, professor of preventive medicine and infectious diseases at Vanderbilt University in Nashville, Tennessee.

Around 12 000 people died of covid-19 worldwide from 1 to 28 May 2023, show data from the World Health Organization. Schaffner says that the patients who are dying are mainly immunocompromised people who are older—and therefore have weaker immune systems—or have underlying conditions such as cancer or an autoimmune disorder or are taking immunosuppressive drugs.

Alex Richter, professor in clinical immunology and director of the Clinical Immunology Service at the University of Birmingham, UK, reiterates this. “Studies are highlighting that although outcomes have improved for immune vulnerable patients, they remain at higher risk than the general population, and this is now included in risk algorithms such as QCovid,1” she says.

What we don’t know is the difference in risk between different types of immunocompromised states. The evidence is not clear cut, says Arturo Casadevall, professor of molecular microbiology and immunology at Johns Hopkins Bloomberg School of Public Health in Baltimore, Maryland. “The data on [how at risk different immunocompromised people are] is fragmentary, since this group is very heterogeneous,” he says. “For example, a patient on corticosteroids is very different from a transplant recipient, who in turn is very different from a person with leukaemia.” Studies suggest that patients with malignancy or solid organ transplants are at greater risk of severe covid-19 …

United-kingdom , Maryland , United-states , Tennessee , Vanderbilt-university , Johns-hopkins-university , British , Alex-richter , Stephen-griffin , Arturo-casadevall , British-society-for-immunology , University-of-birmingham

Answers on vaccines

Answers on vaccines
voice-online.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from voice-online.co.uk Daily Mail and Mail on Sunday newspapers.

United-kingdom , Kenya , London , City-of , British , Anne-wafula-strike , Donald-palmer , Nikki-kanani , Healthcare-products-regulatory-agency , British-society-for-immunology , Health-record , Wafula-strike

Triple jab take up rate drops to 12-year low, say health chiefs

Triple jab take up rate drops to 12-year low, say health chiefs
brightonandhovenews.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from brightonandhovenews.org Daily Mail and Mail on Sunday newspapers.

East-sussex , United-kingdom , West-sussex , Brighton , Brighton-and-hove , British , Doug-brown , World-health-organisation , British-society-for-immunology , United-kingdom-health-security-agency , British-society ,